Solara Active Pharma Sciences Limited
NSE:SOLARA.NS
645.15 (INR) • At close July 29, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) INR.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 12,837.6 | 12,741 | 14,438.1 | 12,305.5 | 15,757.3 | 12,676.4 | 13,220.83 | 5,209.73 | 9,412.78 |
| Kosten van de omzet
| 6,264.1 | 8,385.1 | 7,888.2 | 6,977.9 | 7,695.8 | 6,407.3 | 7,467.73 | 4,473.46 | 5,028.6 |
| Brutowinst
| 6,573.5 | 4,355.9 | 6,549.9 | 5,327.6 | 8,061.5 | 6,269.1 | 5,753.1 | 736.27 | 4,384.18 |
| Brutowinstmarge
| 0.512 | 0.342 | 0.454 | 0.433 | 0.512 | 0.495 | 0.435 | 0.141 | 0.466 |
| Onderzoek- en ontwikkelingskosten
| 0 | 0 | 461.6 | 656.2 | 643.5 | 585.7 | 440.5 | 18.18 | 0 |
| Algemene en administratieve kosten
| 0 | 243.3 | 2,299.2 | 310.3 | 328.5 | 283.4 | 176.4 | 412.9 | 0.204 |
| Verkoop- en marketingkosten
| 0 | 341.8 | 8.6 | 53.9 | 76.2 | 55.1 | 63.09 | 7.48 | -0.187 |
| Verkoop-, algemene en administratieve kosten
| 2,116.9 | 585.1 | 2,307.8 | 364.2 | 404.7 | 338.5 | 239.49 | 420.38 | 0.017 |
| Overige kosten
| 0 | 5,394.5 | 225.5 | 76.3 | 84.6 | 107.9 | 74.67 | -7.87 | 116.13 |
| Bedrijfskosten
| 2,116.9 | 3,998.8 | 6,322.9 | 5,500.3 | 5,257.3 | 4,570.4 | 4,243.72 | 446.43 | 3,799.76 |
| Bedrijfsresultaat
| 4,456.6 | -1,980.8 | 275.9 | -259.9 | 2,846 | 1,731.8 | 1,509.38 | 289.84 | 584.42 |
| Bedrijfsresultaat ratio
| 0.347 | -0.155 | 0.019 | -0.021 | 0.181 | 0.137 | 0.114 | 0.056 | 0.062 |
| Totaal overige inkomsten en kosten netto
| -4,451.2 | -2,903.4 | -779.8 | -651.1 | -3,279.3 | -543.8 | -827.1 | -231.57 | -199.9 |
| Inkomen voor belasting
| 5.4 | -4,884.2 | -448.1 | -911 | 2,215 | 1,149.1 | 676.93 | 58.27 | 384.52 |
| Inkomen voor belasting ratio
| 0 | -0.383 | -0.031 | -0.074 | 0.141 | 0.091 | 0.051 | 0.011 | 0.041 |
| Belastingkosten
| 0 | 785.4 | -225.7 | -328.1 | 1.5 | 3.9 | 5.9 | -1.4 | 84.37 |
| Nettowinst
| 5.4 | -5,673.9 | -221.7 | -581.5 | 2,214 | 1,146.1 | 595.27 | 3.77 | 301.64 |
| Nettowinstmarge
| 0 | -0.445 | -0.015 | -0.047 | 0.141 | 0.09 | 0.045 | 0.001 | 0.032 |
| WPA (Winst Per Aandeel)
| 0.14 | -145.27 | -6.16 | -16.18 | 69 | 44.29 | 24.11 | 0.15 | 26.94 |
| Verwaterde WPA
| 0.14 | -145.27 | -6.16 | -16.18 | 64.53 | 42.82 | 24.07 | 0.15 | 26.94 |
| EBITDA
| 2,062.8 | -2,821.9 | 1,523.6 | 885 | 4,138.5 | 2,859.3 | 2,324.5 | 626.33 | 1,220.62 |
| EBITDA ratio
| 0.161 | -0.221 | 0.106 | 0.072 | 0.263 | 0.226 | 0.176 | 0.12 | 0.13 |